शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
WOCKPHARMANSEWockhardt Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Thu, 21 May, 2026 · 14:24 IST

Wockhardt Limited has informed the Exchange about Credit Rating

Credit rating upgradedCredit & Debt View source PDFExplain this filing

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.1%Reaction day
₹1613.00
prior close
₹1602.70
announcement price
In-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.7%-1.8% vs market
Pharmaceuticals peers, median of 160sector+0.2%-1.2% vs sector

On the reaction day the stock moved 1.8 pts less than Nifty Smallcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.0
15m
-0.2
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.1+0.7-1.8+0.2-1.2
Next day
-2.2+0.6-2.8+0.2-2.4
2d
+2.0+1.8+0.2+1.4+0.6
3d
+6.3+2.0+4.3+1.3+5.0
4d
+10.4+2.6+7.8+1.6+8.8
5d
+25.5+1.9+23.7+1.0+24.5
1w
+22.3+1.6+20.7+0.2+22.1
15d
+20.0+2.4+17.6+0.5+19.5
1m
+24.9+7.0+17.8+2.8+22.0
2m
+17.2+8.5+8.7+6.9+10.3
3m
+17.0+10.4+6.6+7.9+9.1
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

ICRA Limited has upgraded Wockhardt's credit ratings across all its debt instruments from BBB (Positive) to A- (Stable), with short-term ratings also upgraded to A2+. This upgrade reflects the company's improved financial performance, strong market position in formulations in India and Europe, growing presence in emerging markets, adequate liquidity, and a comfortable capital structure. The rating agency also cited scale expansion of value-accretive products and new chemical entities (NCEs) as positive factors.

Likely market impact

This is a positive development for shareholders as the upgrade signals improved creditworthiness and financial health, which could lower borrowing costs and boost investor confidence in the stock.